1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve ReplacementFiras Zahr, Martin B. Leon, Isaac George et al.|JACC: Cardiovascular Interventions|2023Cited by 52
THE EVEREST II HIGH SURGICAL RISK COHORT: EFFECTIVENESS OF TRANSCATHETER REDUCTION OF SIGNIFICANT MITRAL REGURGITATION IN HIGH SURGICAL RISK PATIENTSScott Lim, Ted Feldman, Saibal Kar et al.|Journal of the American College of Cardiology|2013Cited by 6
TCT-89 Percutaneous Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II Randomized, Continued Access, and High Risk Clinical ProgramsSaibal Kar, Ted Feldman, Scott Lim et al.|Journal of the American College of Cardiology|2013Cited by 2
EFFECTIVENESS OF TRANSCATHETER REDUCTION OF SIGNIFICANT MITRAL REGURGITATION IN HIGH SURGICAL RISK PATIENTS WITH MITRACLIP: FINAL 5 YEAR RESULTS OF THE EVEREST II HIGH RISK REGISTRYSaibal Kar, Ted Feldman, Patrick L. Whitlow et al.|Journal of the American College of Cardiology|2014Cited by 1